STAAR Surgical Company

NASDAQ:STAA

Medical - Instruments & Supplies

Healthcare
$25.35 -1.37%

-$0.40 today

Market cap
$1.27B
Beta
1.23
P/E (TTM)
-68.3
EPS (TTM)
-$0.42
52W Low $15.59High $35.87

Volume 0.45M

Average 1.07M

STAA Interest Expense

Cost of servicing the company's debt during the period.

STAAR Surgical CompanyNASDAQ: STAA

Interest Expense · Q1 FY2026 · quarter ended Apr 2026

Interest expense remains negative

Q1 FY2026 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $0.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$0— QoQ
Last fiscal yearJan 2026
$0— YoY
LTMApr 2026
$0— YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Expense vs competitors

How STAA compares with its peers on the latest reported figures

  • STAA's LTM Apr 2026 interest expense of $0 is the lowest of the 5 companies compared; the peer median is $151.79M.
  • Interest expense amounts to 0.0% of revenue for STAA, versus a peer median of 2.1%.
STAA Competitors Peer median
Interest Expense for STAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BLCOBausch + Lomb CorporationLTM Jun 2026$396M -7.0%+43.5%7.4%
ALCAlcon Inc.LTM Sep 2026$208.99M +4.6%+13.8%1.9%
COOThe Cooper Companies, Inc.LTM Jul 2026$94.6M -15.3%+20.4%2.2%
RXSTRxSight, Inc.LTM Mar 2026$17K -22.7%-79.9%0.0%
STAASTAAR Surgical CompanyLTM Apr 2026$0 ——0.0%
Peer median (excluding STAA) $151.79M-11.2%+17.1%2.1%

Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue230.47M284.39M322.42M313.9M239.44M
Cost of Revenue51.84M61.01M69.76M74.32M57.02M
Gross Profit178.64M223.38M252.65M239.58M182.42M
Gross Margin77.5%78.5%78.4%76.3%76.2%
Research & Development33.86M35.98M44.4M53.97M40.06M
Selling, General & Admin111.44M143.6M180.15M198.22M188.31M
Operating Expenses145.3M179.58M224.55M252.19M228.37M
Depreciation & Amortization3.64M4.51M5.12M6.89M8.73M
EBITDA34.98M50.06M38.82M(2.16M)(73.54M)
EBITDA Margin15.2%17.6%12.0%-0.7%-30.7%
Operating Income33.34M43.8M28.1M(12.61M)(45.95M)
Operating Margin14.5%15.4%8.7%-4.0%-19.2%
Interest Income—2.45M6.99M5.91M4.59M
Interest Expense38K0000
Other Income / Expenses(2.04M)1.75M5.6M3.56M(36.32M)
Income Before Tax31.3M45.55M33.7M(9.05M)(82.26M)
Pre-Tax Margin13.6%16.0%10.5%-2.9%-34.4%
Income Tax Expense3.79M5.89M12.35M11.16M(1.82M)
Net Income27.51M39.67M21.35M(20.21M)(80.45M)
Net Margin11.9%13.9%6.6%-6.4%-33.6%
EPS (Basic)0.520.830.44(0.41)(1.62)
EPS (Diluted)0.500.800.43(0.41)(1.62)
Weighted Avg Shares47.21M47.99M48.52M49.13M49.57M
Weighted Avg Shares (Diluted)49.46M49.38M49.43M49.13M49.57M

STAAR Surgical Company

NASDAQ:STAA

Intrinsic Alpha fair value

Locked

Current Price

$25.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.